{Etokimab: A Deep Investigation into the 2022981-44-6 Antibody Etokimab, designated by the unique identifier 2022981-44-6, represents a emerging antibody currently undergoing clinical evaluation. This medicinal agent, https://www.targetmol.com/compound/etokimab